http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08291179-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64ce9e67b090644ea50f977c57776a34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-13 |
| filingDate | 1995-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3255d4a9ffafa18a997cdd0836fee690 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ee18ce58c309a678cf014c484864e53 |
| publicationDate | 1996-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H08291179-A |
| titleOfInvention | Dioxaborinane compound and liquid crystal composition containing the same |
| abstract | (57) [Summary] [Object] To provide a dioxaborinane compound useful as a liquid crystal compound. [Structure] A compound represented by the general formula (2) such as the compound (1), a liquid crystal composition containing the compound, and a liquid crystal optical element. However, R 1 is alkyl or alkenyl, and is A 1 to A 1. 3 is phenyl or cyclohexylene, Z 1 to Z 4 are single bonds, and B is 1,4-dioxaborinane. Embedded image nC 3 H 7 -B-Ph-Cy-CH = CF 2 (1) R 1- (A 1 -Z 1 ) k -B- (Z 2 -A 2 ) p- (Z 3 -A 3) m -Z 4 - (CH 2) n -CX 1 = CFX 2 (2) |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014160384-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005298466-A |
| priorityDate | 1995-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.